Regeneron might be ready for competition with its blockbuster drug Eylea, but it’s not clear that investors are.
On Thursday morning, the biotech’s leadership fielded …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
VANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging
The concept of “One Health” – which emphasizes the relationship between human, animal, plant and environmental health – has been gaining ground in scientific discussions
Submaximal balloon angioplasty for symptomatic intracranial atherosclerotic stenosis (ICAS) improved outcomes over aggressive medical management alone, the BASIS trial from China showed. The incidence of